AN ACT CONCERNING HEALTH INSURANCE COVERAGE OF ORALLY AND INTRAVENOUSLY ADMINISTERED MEDICATIONS.
To require health insurance policies that provide coverage for prescription drugs to provide coverage for intravenously administered drugs on a basis no less favorable than orally administered drugs.
Introduced by:Insurance and Real Estate Committee
|New today||2-4 days old||5 days & older|
Add Notes to SB-21
Co-sponsors for Amendment LCO:
|3/10/2017||Favorable Change of Reference, Senate to Committee on Appropriations|
|3/10/2017||(LCO)||Reported Out of Legislative Commissioners' Office|
|3/8/2017||(LCO)||Filed with Legislative Commissioners' Office|
|3/7/2017||(INS)||Joint Favorable Change of Reference Appropriations|
|3/1/2017||Referred to Joint Committee on Insurance and Real Estate|
|2/28/2017||Drafted by Committee|
|2/23/2017||(INS)||Vote to Draft|
|2/2/2017||Public Hearing 02/07|
|1/19/2017||(INS)||Reserved for Subject Matter Public Hearing|
|1/9/2017||Referred to Joint Committee on Insurance and Real Estate|